CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons [version 2; referees: 2 approved]

by Manoj P. Ramteke, Kuldeep J Patel, Mukul Godbole, Maulik Vyas, Kunal Karve, Anuradha Choughule, Kumar Prabhash, Amit Dutt
Published 2016-03-01

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulati...

by Maulik Vyas, Silke Reinartz, Nathalie Hoffmann, Katrin S. Reiners, Sonja Lieber, Julia M. Jansen, Uwe Wagner, Rolf Müller, Elke Pogge von Strandmann
Published 2017-09-01

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

by Stephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, Tanja Gardlowski, Nadine Matthies, Maulik Vyas, Lubomir Arseniev, Michael Heuser, Elke Pogge von Strandmann, Ulrike Köhl
Published 2017-09-01

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

by Stephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, Tanja Gardlowski, Nadine Matthies, Maulik Vyas, Lubomir Arseniev, Michael Heuser, Elke Pogge von Strandmann, Ulrike Köhl
Published 2018-10-01